Researchers demonstrate that combinations of antiviral drugs inhibiting both polymerase and exonuclease reduce SARS-CoV-2 replication 10 times more than polymerase inhibitors alone.
Click here for original story, Novel antiviral drug combinations demonstrate COVID-19 therapeutic potential
Source: ScienceDaily